Travel slowdown leads Marriott to cut 2025 guidance
In the first quarter of 2025, Marriott saw global revenue per available room (RevPAR)—a key industry metric—rise by 4.1% compared to the same period last year. Growth was driven by a 3.3% increase in the U.S. and Canada, and a stronger 5.9% uptick across international markets.
The company reported a net income of $665 million, with adjusted net income reaching $645 million. Diluted earnings per share stood at $2.39, while adjusted diluted EPS came in at $2.32. Adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) totalled $1.22 billion for the quarter.
Despite these positive indicators, Marriott's leadership flagged emerging pressures on global travel demand, prompting a slight revision to its full-year projections. The company now expects more modest revenue growth over the coming quarters as economic headwinds begin to weigh on leisure and corporate travel.
Marriott added approximately 12,200 net rooms in the first quarter, representing a 4.6% increase compared to the same period in 2024. The company's global development pipeline remains strong, with around 3,800 hotels and more than 587,000 rooms in planning or under construction.
This marks a 7.4% increase in pipeline growth year-over-year, highlighting sustained interest from developers and franchisees despite market uncertainties.
The group continues to focus on strategic growth, particularly in high-demand international regions, where RevPAR growth outpaced that of North America. Executives reaffirmed confidence in the long-term fundamentals of the travel industry, even as they acknowledged near-term volatility.
Marriott maintained its commitment to returning value to shareholders. In the first quarter alone, the company repurchased 2.8 million shares of common stock for a total of $800 million.
By the end of April, total capital returned to shareholders for the year had surpassed $1.2 billion, including both dividends and buybacks.
While macroeconomic conditions have introduced a degree of caution into the company's guidance, Marriott's overall financial health remains strong, underpinned by a diversified global footprint and ongoing expansion plans.
Although Marriott has moderated its outlook, the company remains on solid ground. The first-quarter performance reflects sustained post-pandemic travel momentum, particularly in international markets.
However, the more tempered forecast suggests a recognition of changing economic dynamics and a pragmatic approach to navigating the rest of 2025.
Marriott's detailed financial report is available on its investor relations website: Marriott Q1 2025 Results.
"Travel slowdown leads Marriott to cut 2025 guidance" was originally created and published by Hotel Management Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
International Flavors and Fragrances beats quarterly revenue, profit estimates
(Reuters) -International Flavors and Fragrances topped Wall Street estimates for second-quarter revenue and profit on Tuesday, driven by resilient demand, higher prices and a shift to better-margin businesses. The company has streamlined its portfolio as choppy demand in some food and beauty markets forced its customers to hold leaner inventories. On Tuesday, the company, which disposed of its pharma solutions business earlier this year, said it would sell its soy crush, concentrates, and lecithin unit to U.S. grain trader and processor Bunge Global. IFF did not disclose financial terms but said the operations generated about $240 million in revenue in 2024. The company posted net sales of $2.76 billion for the quarter ended June 30, beating estimates of $2.70 billion, according to data compiled by LSEG. Its adjusted profit of $1.15 per share also topped expectations of $1.12. Advance purchases by packaged food and beauty companies looking to beat higher prices due to tariffs also boosted sales at IFF in the reported quarter. "We remain on track to deliver our 2025 commitments we outlined earlier this year, even as the operating environment has become more challenging," said CEO Erik Fyrwald. IFF's shares were up nearly 5% in extended trading. They have fallen about 16% so far this year. The New York-headquartered company maintained its annual sales and adjusted core profit targets. The company also said it authorized a new share buyback program with a total value of $500 million. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
Long-Term Unemployment Rises In Worrying Sign For U.S. Labor Market
WASHINGTON – Signals of labor market weakness go beyond the headline numbers that prompted President Donald Trump to fire the government's head statistician last week. The jobs report released Friday showed a slowdown in hiring, a slight uptick in the national unemployment rate, and a few other clues that the economy is softening — including an increase in long-term unemployment. The number of people jobless for six months or more increased from 1.6 million to 1.8 million in July, representing 24% of the unemployed. It's the most people experiencing long-term joblessness since the end of 2021 and the highest percentage since February 2022, when the economy was still recovering from coronavirus lockdowns. Valerie Wilson, a labor economist at the liberal Economic Policy Institute, said the modest rise in long-term joblessness could reflect employers getting pickier about hiring as President Donald Trump's tariff regime changes the cost of doing business. 'People who have been unemployed for longer have clearly had some challenges in getting back into the labor market,' Wilson told HuffPost. 'I think that as things have softened, and employers are facing more uncertainty given the sort of chaotic nature of economic policy in this country, that it would be harder for those people to find new jobs.' The president's tariffs on goods imported from other countries are tantamount to a $1,219 tax increase on American households this year, according to an estimate by the conservative Tax Foundation. HuffPost readers: Dealing with long-term unemployment? Tell us about it – email arthur@ Please include your phone number if you're willing to be interviewed. Persistently high long-term joblessness was a hallmark of slow recovery from the Great Recession that officially ended in 2009. It disproportionately affected older workers, becoming a self-perpetuating problem as employers sought job applicants with minimal or no gaps on their resumes. Some economists worry another recession could be around the corner. The overall unemployment rate remained low in July, at just 4.2%, and the economy has continued to add jobs, albeit at a slower pace than previously estimated. Bureau of Labor Statistics data suggest the last three months were the weakest for job growth since the pandemic. Trump fired the BLS commissioner on Friday, claiming without evidence that the numbers were somehow 'rigged' to make him look bad. The labor force shrank slightly in July, helping hold down the unemployment rate even as the number of employed workers declined. Wilson noted the unemployment rate for Black Americans rose to 7.2%, up from a recent historical low of 4.8% in April 2023. 'Over the last two months, we're seeing the black unemployment rate pick up, which is another one that as that starts to rise, we start to look for signals of a broader slowing in the economy,' Wilson said.
Yahoo
26 minutes ago
- Yahoo
Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations
DURHAM, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the appointment of Tracy Krumme as senior vice president, investor relations, succeeding Hima Inguva in this role, who has decided to pursue other career opportunities. Krumme will report to Chief Financial Officer, Jill McConnell, and lead Fortrea's global investor relations strategy, serving as a key liaison to the investment community. 'Tracy is a seasoned executive with the strategic mindset and investor acumen needed as Fortrea enters its next chapter,' said McConnell. 'She brings not only deep capital markets expertise but also integrity, insight and a strong track record of supporting strategic transformation and growth. We're excited to welcome her to the team. I also would like to express my sincere appreciation to Hima Inguva, who has led Fortrea's Investor Relations since our founding as a company. We wish her every success in her next chapter.' Krumme brings more than three decades of investor relations and capital markets experience to Fortrea, with expertise across the CRO, life sciences and healthcare sectors. She previously served as head of investor relations at PPD, a leading CRO acquired by Thermo Fisher Scientific, where she worked alongside Fortrea's CEO Anshul Thakral; Galderma, a global dermatology company; and Nuance Communications, a provider of healthcare AI solutions acquired by Microsoft. Most recently, she was senior vice president, head of investor relations and corporate communications at Bitfarms, a global energy and compute infrastructure company. Earlier in her career, she led investor relations at Luxoft, acquired by DXC Technology, and NCR Corporation, and held roles as an equity research analyst at Sandler O'Neill & Partners and in corporate finance at Prudential Securities and Kidder, Peabody International in London. 'I'm excited to join Fortrea at such a pivotal moment in its evolution as an independent, pure-play CRO,' said Krumme. 'I look forward to working with the leadership team to articulate Fortrea's vision and value proposition to the investment community as we deliver differentiated solutions to our customers and generate long-term value for shareholders.' About Fortrea Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at and follow us on LinkedIn and X (formerly Twitter). Fortrea Contacts: Tracy Krumme (Investors) – 984-385-6707, Inguva (Investors) – 877-495-0816, Sue Zaranek (Media) – 919-943-5422, media@ Kate Dillon (Media) – 646-818-9115, kdillon@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
